Jürgen Bosch

Center for Global Health — United States

Medicine · Health Sciences

32h-index11.6kcitations163works1.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Malaria Research and Control(27), Ubiquitin and proteasome pathways(18), Multiple Myeloma Research and Treatments(15), Trypanosoma species research and implications(13), Enzyme Structure and Function(13)

Publications159 total

Immunologic Evaluation of First and Second Doses of <scp>SARS‐CoV‐2 XBB.1.5</scp> and the <scp>KP.2</scp> Monovalent Booster Vaccines in Nursing Home Residents
Journal of the American Geriatrics Society·2025Open Access
Non-neutralizing antibodies against SARS-CoV-2 nucleocapsid protein mediate variant transcendent antibody-dependent cellular cytotoxicity
The Journal of Immunology·2025Open Access
Development of novel Aotus nancymaae Non-human primate model for the evaluation of Plasmodium vivax blood stage vaccines and immunoprophylactics
2025Open Access
P-2066. Impact of XXB 1.5 Monovalent Booster Vaccination on Mucosal and Systemic Immune Responses in Healthy Adults
Open Forum Infectious Diseases·2025Open Access
Antibody Responses to SARS-CoV-2 Vaccine in Nursing Home Residents Support a Bi-Annual Update Schedule
2025Open Access
Potent AMA1-specific human monoclonal antibody against Plasmodium vivax Pre-erythrocytic and Blood Stages
Nature Communications·2024· 4 citedOpen Access
Pre-exposure immunohematologic features of heart failure associate with COVID-19 mortality
npj Cardiovascular Health·2024· 1 citedOpen Access
COVID-19 Booster Doses Reduce Sex Disparities in Antibody Responses among Nursing Home Residents
2024Open Access
Broad immunogenicity to prior SARS-CoV-2 strains and JN.1 variant elicited by XBB.1.5 vaccination in nursing home residents
GeroScience·2024· 5 citedOpen Access
Novel hydrazone compounds with broad-spectrum antiplasmodial activity and synergistic interactions with antimalarial drugs
Antimicrobial Agents and Chemotherapy·2024· 5 citedOpen Access
Broad immunogenicity to prior SARS-CoV-2 strains and JN.1 variant elicited by XBB.1.5 vaccination in nursing home residents
2024· 4 citedOpen Access
Potent AMA1-specific human monoclonal antibody against P. vivax Pre-erythrocytic and Blood Stages
2024Open Access
Potent AMA1-specific human monoclonal antibody against P. vivax Pre-erythrocytic and Blood Stages
2024Open Access
Human monoclonal antibodies inhibit invasion of transgenic Plasmodium knowlesi expressing Plasmodium vivax Duffy binding protein
Malaria Journal·2023· 6 citedOpen Access
Duffy antigen is expressed during erythropoiesis in Duffy-negative individuals
Cell Host & Microbe·2023· 18 citedOpen Access
2373. "Longitudinal Investigation of Avidity Maturation following Multiple Doses of BNT162b2 mRNA Vaccine Including Bivalent Boosters among Nursing Home Residents and Healthcare Workers"
Open Forum Infectious Diseases·2023Open Access
Neutralization and binding antibody response to second bivalent <scp>COVID</scp> ‐19 vaccination in nursing home residents
Journal of the American Geriatrics Society·2023· 6 citedOpen Access
Durability of immunity and clinical protection in nursing home residents following bivalent SARS-CoV-2 vaccination
2023· 7 citedOpen Access
Supplemental Figure 1 from Identification of Novel Ezrin Inhibitors Targeting Metastatic Osteosarcoma by Screening Open Access Malaria Box
2023Open Access
Supplemental Figure 1 from Identification of Novel Ezrin Inhibitors Targeting Metastatic Osteosarcoma by Screening Open Access Malaria Box
2023Open Access
page 1 of 8Next →

Frequent Co-authors

Wim G. J. Hol(9), Lauren Boucher(7), Frederick S. Buckner(5), Frank Zucker(5), Wesley C. Van Voorhis(4), Christopher Mehlin(4), Peter J. Myler(4), George T. DeTitta(4), Joseph R. Luft(4), M. Soltis(4), E.A. Merritt(4), Christophe L. M. J. Verlinde(4), Adelaide U.P. Hain(4), Bodo Eickhoff(4), Stephan Rüller(4), Max Schlaak(4), J.M. Caruthers(4), Claudia Roach(3), Chr. Schudt(3), Dirk Pette(3)